Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$1.22B |
| 3 |
NVIDIA
NVDA
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$1.01B |
| 5 |
Procter & Gamble
PG
|
+$784M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$619M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$582M |
| 3 |
Phillips 66
PSX
|
+$575M |
| 4 |
Eli Lilly
LLY
|
+$377M |
| 5 |
HES
Hess
HES
|
+$326M |
Sector Composition
| 1 | Technology | 31.4% |
| 2 | Financials | 12.71% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Healthcare | 9.99% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Rocket Pharmaceuticals
RCKT
$341M
| $2.84M | ﹤0.01% |
105,505
-72,030
| -41% | -$1.94M |
|
|
VMCAW
1677
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
| $2.83M | ﹤0.01% |
250,000
| – | – |
|
1678
Brinker International
EAT
$6.84B
| $2.81M | ﹤0.01% |
56,551
-44,980
| -44% | -$2.24M |
|
1679
Avista
AVA
$2.95B
| $2.81M | ﹤0.01% |
80,167
-49,987
| -38% | -$1.75M |
|
1680
Primoris Services
PRIM
$6.59B
| $2.81M | ﹤0.01% |
65,940
-34,776
| -35% | -$1.48M |
|
1681
Informatica
INFA
$7.55B
| $2.8M | ﹤0.01% |
80,091
+57,879
| +261% | +$2.03M |
|
1682
Bloomin' Brands
BLMN
$577M
| $2.8M | ﹤0.01% |
97,667
-122,465
| -56% | -$3.51M |
|
1683
Celldex Therapeutics
CLDX
$1.62B
| $2.8M | ﹤0.01% |
66,714
-79,180
| -54% | -$3.32M |
|
1684
Albany International
AIN
$1.71B
| $2.79M | ﹤0.01% |
29,875
-19,303
| -39% | -$1.81M |
|
1685
Ares Capital
ARCC
$15.7B
| $2.79M | ﹤0.01% |
134,070
+129,600
| +2,899% | +$2.7M |
|
1686
Under Armour Class C
UA
$2.04B
| $2.79M | ﹤0.01% |
389,892
-7,428
| -2% | -$53.1K |
|
1687
CarGurus
CARG
$3.58B
| $2.78M | ﹤0.01% |
120,606
-49,790
| -29% | -$1.15M |
|
1688
QuidelOrtho
QDEL
$1.94B
| $2.78M | ﹤0.01% |
58,098
+15,231
| +36% | +$730K |
|
1689
Chegg
CHGG
$167M
| $2.78M | ﹤0.01% |
367,387
+101,477
| +38% | +$768K |
|
1690
Yelp
YELP
$1.95B
| $2.78M | ﹤0.01% |
70,464
-45,086
| -39% | -$1.78M |
|
1691
Eldorado Gold
EGO
$5.7B
| $2.78M | ﹤0.01% |
197,280
-15,433
| -7% | -$217K |
|
1692
Diebold Nixdorf
DBD
$2.17B
| $2.76M | ﹤0.01% |
80,247
+28,736
| +56% | +$990K |
|
1693
Arcellx
ACLX
$4.23B
| $2.76M | ﹤0.01% |
39,703
-89,723
| -69% | -$6.24M |
|
1694
MP Materials
MP
$11.2B
| $2.76M | ﹤0.01% |
192,691
+9,823
| +5% | +$141K |
|
|
ABPWW
1695
Abpro Holdings, Inc. Warrant
ABPWW
| $2.75M | ﹤0.01% |
250,000
| – | – |
|
1696
Supernus Pharmaceuticals
SUPN
$2.55B
| $2.75M | ﹤0.01% |
80,576
-22,223
| -22% | -$758K |
|
1697
Kennametal
KMT
$1.58B
| $2.75M | ﹤0.01% |
110,099
-56,216
| -34% | -$1.4M |
|
1698
Equinox Gold
EQX
$8.29B
| $2.73M | ﹤0.01% |
452,921
-18,382
| -4% | -$111K |
|
|
PRFT
1699
DELISTED
Perficient Inc
PRFT
| $2.73M | ﹤0.01% |
48,418
-55,541
| -53% | -$3.13M |
|
1700
Central Garden & Pet Class A
CENTA
$2.03B
| $2.72M | ﹤0.01% |
73,789
-34,724
| -32% | -$1.28M |
|